Patents

US 10682341 B2: Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

Granted
2020-06-16
Filed
2019-01-30 application 16262461
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The current invention is in the field of molecular biology/pharmacology and provides methods of using compounds that modulate the effects of GPR30/GPER for treating obesity and diabetes (preferably agonists) as well as disease states and/or conditions that result from excessive formation of reactive oxygen species (preferably antagonists). These compounds may function as agonists and/or antagonists of the disclosed estrogen receptor and/or modulate the expression/upregulation of nox and nox-associated reactive oxygen species (ROS).

Source: PVGPATDIS, file of 2026-04-10 (ipg200616.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
STC.UNM 475 patentsUS company or organizationAlbuquerque, NMPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Eric R. ProssnitzAlbuquerque, NM9PVGPATDIS, file of 2026-04-10
Matthias BartonZürich, CH4PVGPATDIS, file of 2026-04-10
Matthias R. MeyerStallikon, CH4PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/436PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P3/10PVGPATDIS, file of 2026-04-10
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N2800/042PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2020-11-18Name change
Change of name
STC.UNM signed 2020-06-03UNM RAINFOREST INNOVATIONS ALBUQUERQUE, NM54403/714ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.